Comparison of Outcomes Following a Switch from a Brand to an Authorized vs. Independent Generic Drug

被引：0
|
作者：
Hansen, Richard A. [1 ]
Qian, Jingjing [1 ]
Berg, Richard [2 ]
Linneman, James [2 ]
Seoane-Vazquez, Enrique [3 ]
Dutcher, Sarah [4 ]
Raofi, Saeid [4 ]
Peissig, Peggy [2 ]
机构：
[1] Auburn Univ, Dept Hlth Outcomes Res & Policy, Harrison Sch Pharm, Auburn, AL 36849 USA
[2] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA
[3] Massachusetts Coll Pharm & Hlth Sci, Int Ctr Pharmaceut Econ & Policy, Boston, MA USA
[4] US FDA, Off Gener Drugs, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1036
引用
收藏
页码：602 / 603
页数：2
相关论文
共 50 条
  • [1] Comparison of Outcomes Following a Switch From a Brand to an Authorized Versus Independent Generic Drug
    Hansen, R. A.
    Qian, J.
    Berg, R. L.
    Linneman, J. G.
    Seoane-Vazquez, E.
    Dutcher, S.
    Raofi, S.
    Page, C. D.
    Peissig, P. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) : 310 - 317
  • [2] Comparison Of Generic-To-Brand Switchback Patterns For Authorized Generic Vs. Independent Generic Drugs
    Hansen, Richard A.
    Qian, Jingjing
    Berg, Richard
    Linneman, James
    Seoane-Vazquez, Enrique
    Dutcher, Sarah
    Raofi, Saeid
    Peissig, Peggy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 355 - 356
  • [3] Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs
    Hansen, Richard A.
    Qian, Jingjing
    Berg, Richard
    Linneman, James
    Seoane-Vazquez, Enrique
    Dutcher, Sarah K.
    Raofi, Saeid
    Page, C. David
    Peissig, Peggy
    PHARMACOTHERAPY, 2017, 37 (04): : 429 - 437
  • [4] Branded drug reformulation: The next brand vs. generic antitrust battleground
    Amoresano, Guy V.
    FOOD AND DRUG LAW JOURNAL, 2007, 62 (01) : 249 - 256
  • [5] What's in a name? Use of brand vs. generic drug names
    Citrome, L.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (01) : 3 - 4
  • [6] Comparative Outcomes of Treatment Initiation With Brand vs. Generic Warfarin in Older Patients
    Desai, Rishi J.
    Gopalakrishnan, Chandrasekar
    Dejene, Sara
    Sarpatwari, Ameet S.
    Levin, Raisa
    Dutcher, Sarah K.
    Wang, Zhong
    Wittayanukorn, Sara
    Franklin, Jessica M.
    Gagne, Joshua J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1334 - 1342
  • [7] Physician use of brand vs. generic drug names in the United States from 1993 to 2004.
    Kwo, E.
    Kamat, P.
    Steinman, M. A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S93 - S93
  • [8] Determinants of generic vs. brand drug choice: Evidence from population-wide Danish data
    Skipper, Niels
    Vejlin, Rune
    SOCIAL SCIENCE & MEDICINE, 2015, 130 : 204 - 215
  • [9] Severe cutaneous adverse reaction to drug excipient following brand-to-generic switch of levetiracetam
    Lim, Jo Anne
    Jamil, Adawiyah
    Ramli, Nur Amalina
    Johar, Fatimah Mat
    Nor, Mokhtar
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (03) : e69 - e72
  • [10] Efficacy of brand-name vs. generic fluoxetine
    Shields, BJ
    Nahata, MC
    PERSPECTIVES IN PSYCHIATRIC CARE, 2003, 39 (03) : 122 - +
12345